Antonella Mancuso named chief manufacturing officer of Patheon; Allergan invests $350 million in plant in Ireland;

> Antonella Mancuso has been promoted to global commercial operations president and chief manufacturing officer for drug development and manufacturing services company Patheon ($PTI.TO). Release

> Allergan ($AGN) will invest about $350 million for a Botox manufacturing facility in Westport in County Mayo, Ireland, in the next four years. Eventually, it expects to have 1,050 working at the facility in the town of 6,000. Story

> Boehringer Ingelheim introduced what it calls a "Lean-to-Clinic" service, which it claims will deliver drug substances for toxicological and clinical studies in 13 months and drug products for clinical studies after 16 months. Release

> The FDA has updated its Q&A page to help manufacturers of topical antiseptics prevent contamination. Story

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.